A hallmark of CML is the well-characterised t(9; 22) aberration, otherwise known as the Philadelphia chromosome [35], which results in the BCR-ABL fusion gene in over 95% of patients [36]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.